Analysis: ICICI Bank Limited

NSE:ICICIBANK Banks - Private Market cap: ₹10.3L cr

Growth thesis

ICICI Bank is an Indian private sector lender that earns its return from the spread between a low-cost deposit franchise and a deliberately diversified loan book: retail and rural combined at 43% of loans including non-fund based outstanding, business banking, domestic corporate, and an overseas branch book that is now 7.8% of advances. At September 30, 2026 total loans grew 30% year-on-year and 12% sequentially, or 24.1% and 7.3% stripping out international branch lending against FCNR(B) deposits. Deposits grew 27.1% year-on-year, or 17% excluding roughly $18 billion of FCNR(B) money raised under the RBI swap facility. Net interest income rose 17.7% year-on-year to Rs 253.39 billion, fee income 20.1% to Rs 77.95 billion, and profit before tax excluding treasury 23.4% to Rs 199.54 billion.

The business economics rest on three things. First, funding. Cost of deposits was 4.50% in Q2 FY27, still below the 4.64% of a year earlier despite a richer term-deposit mix, and average CASA deposits grew 10.7% year-on-year. Second, pricing discipline that is stated rather than assumed. Management repeatedly says it walks away from corporate loans that fail its risk-adjusted return test, and in Q2 FY27 argued that corporate credit loss is structurally lower than retail because the corporate decision is a go/no-go on return of capital at client level, with transaction banking and collections revenue outside the lending spread. Third, a provisioning buffer that is large relative to reported credit cost: contingency provisions of Rs 131.00 billion, about 0.7% of advances, plus total provisions outside specific NPA provisions of Rs 238.15 billion or 1.3% of loans, against provisions of Rs 8.51 billion in the quarter.

What has changed in this reporting cycle is the margin arithmetic. NIM fell to 4.18% from 4.36% in Q1 FY27 and 4.30% a year earlier, because the overseas share of the book rose from 3.1% to 7.8% and a larger retail term deposit base diluted the average CASA ratio. Management quantified why this matters and why it thinks it reverses: the overseas book earns roughly 1% against 4%+ domestically, the full-quarter effect lands in Q3 FY27, and "from Q4, I would expect margins to, you know, come back in a pretty healthy way", explicitly assuming no further rate hikes. That is guidance, not an achieved fact, and it is the single most important testable claim management has made this cycle. Excess liquidity is expected to be deployed over the next two quarters into the seasonally strong credit period, which is the mechanism by which the recovery is supposed to happen.

The earnings path that follows is unusually clean for a bank. Provisions were 0.2% of average advances in Q2 FY27 - well below the up to 50 basis point normalised level management itself keeps restating - so the base is flattered rather than burdened. Fee growth is granular, with 75% from retail, rural and business banking relationships, and operating expenses grew 8.5% year-on-year against 20.1% fee growth and 17.7% net interest income growth, so the operating jaws are positive. The cost of that cleanliness is that the next leg of profit growth has to come from volume and mix, not from further provisioning releases; the reported credit cost can only normalise upward from here.

Capital allocation is conservative and readable. CET-1 was 16.01% and total capital adequacy 16.68%, ample against growth of this pace, and management's stated preference from April 2025 onwards has been to keep capital for franchise growth rather than lift payouts. The one new allocation decision is small and strategic: Rs 14.7 billion for an additional 2% of ICICI Life Insurance, lifting ownership in a subsidiary that earned Rs 7.60 billion of profit after tax in H1 FY27 on a 26% value-of-new-business margin. Branch expansion is running at 145 net additions in H1 FY27 to 7,656, without a disclosed outlay.

Management delivery is mixed but honest. The 50 basis point credit cost anchor has been repeated for over a year and reported outcomes have stayed below it. Personal loans did turn from a declining book to 16.6% year-on-year growth, as guided. Business banking did grow faster than the loan book, as guided in July 2025. But the FY27 "range-bound NIM" view did not survive contact with the bank's own FCNR(B) decision, and the Rs 12.83 billion agricultural PSL provision, first disclosed in January 2026 as a portfolio to be remediated, was still held at September 30, 2026 with a write-back now conditioned on the regulator being satisfied with the remediation rather than on an internal timetable. Neither is a solvency issue; both are reasons to discount forward guidance slightly.

The falsifiers are specific. Margins failing to recover in Q4 FY27 would mean the overseas mix effect is permanent rather than transient, and would cut the earnings path materially because the deposit repricing lever would have been spent. Normalised credit cost settling above 50 basis points would signal that business banking, compounding at 33.8% with part of the growth from ECLGS drawdowns, or a corporate book growing 30.6%, is seasoning worse than the record shows; corporate and business banking net NPA additions already turned from net deletions of Rs 0.53 billion to net additions of Rs 1.08 billion. Deposit growth of 17% excluding FCNR(B) failing to keep pace with ex-FCNR loan growth of 24.1% would force costlier wholesale funding. And the credit card book, down 9.7% year-on-year, would keep suppressing fee growth if management's Q3 seasonal build does not materialise.

The compounding case, then, is not a re-rating story about a bank with no problems; it is about a franchise whose funding advantage and pricing discipline let it grow a granular, secured book faster than the system while holding asset quality metrics that improved to a 0.30% net NPA ratio this quarter. The specific thing investors are paying for is the durability of that spread once the FCNR(B) trade washes through average balances over the next two quarters.

Why is ICICI Bank Limited stock rising?

  • Total loans grew 30% year-on-year and 12% sequentially at September 30, 2026, but 24.1% and 7.3% excluding international branch lending against FCNR(B) deposits. The ex-FCNR number is the real franchise measure, and management said the excess liquidity is expected to be deployed over the next two quarters in the seasonally strong credit period.
  • NIM fell to 4.18% in Q2 FY27 from 4.36% as the overseas book and retail term deposits diluted the mix. Management guided the full-quarter effect to show up in Q3 FY27 and then margins to come back 'in a pretty healthy way' from Q4 FY27 assuming no further rate hikes, which would make Q3 the trough rather than a new run-rate.
  • Reported provisions were Rs 8.51 billion, or 0.2% of average advances, against Rs 9.14 billion a year earlier. Management reiterated that adjusting for one-off corporate recoveries, the standard asset provision on FCNR(B)-linked loans and KCC seasonality, the normalised credit cost remains up to 50 basis points - the same anchor it has repeated since 2025.
  • Business banking grew 33.8% year-on-year and 11.1% sequentially at September 30, 2026, up from 28.2% and 6.9%. Management said NPL formation in the segment continues to be quite low and that part of the growth came from ECLGS drawdowns, with the rest from new customers and higher working capital use by existing clients.
  • Domestic corporate grew 30.6% year-on-year and 10.4% sequentially, with the builder book's weak-credit share down to 0.5% and NBFC/HFC exposure at 4.3% of advances. Management argued corporate credit costs should sustainably be lower than retail because the decision is a go/no-go on return of capital at client level, and said 'corporate is definitely not worse than retail' on returns.

Research report

companyname: ICICI Bank Limited ticker: ICICIBANK sector: Banking / Financial Services ICICI Bank is a full-service Indian private sector bank incorporated in 1994. It collects deposits and makes loans across retail, rural, business banking, corporate and international segments, and it distributes insurance, asset management and securities products through subsidiaries. The strategic metric management runs the bank on is profit before tax excluding treasury, which grew 23.4% year-on-year to Rs ...

Read the full report →

Catalysts

none

Growth guidance

Guidance given on 17 October 2026: margins moderate further in Q3 FY27 as the full-quarter impact of FCNR(B) deposits and a larger overseas book enters average balances, partly offset by a rate hike already delivered, before margins 'come back in a pretty healthy way' from Q4 FY27 assuming no further rate hikes; excess liquidity is expected to be deployed over the next two quarters; normalised credit cost stays at up to 50 basis points; and the agricultural PSL standard asset provision remains in place till the review process completes. No numeric loan growth, NIM or deposit target was given.

Guidance maintained

Management consistency

consistent

RS rating: 60 Stage: Stage 3

Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for ICICI Bank Limited and 4,900+ companies.

Sign in
5-day free pass. No card required.